Kopran Ltd. (KOPRAN): Kopran Ltd Share Price Rises 8.75% as Stock Gains Today
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
Kopran Ltd Share Price rose 8.75% to Rs 271.50 today, adding Rs 21.85 in value. The company’s market capitalisation stands at Rs 1,137.37 crore, and the supplied data confirms the price event but does not establish a company-specific catalyst.
Kopran Ltd Share Price today moved higher to Rs 271.50, up 8.75% from the previous close of Rs 249.65. The stock added Rs 21.85 during the session, with the day’s range spanning Rs 238.30 to Rs 274.60 and the open at Rs 253.40. Kopran’s market capitalisation now stands at Rs 1,137.37 crore, while turnover came to Rs 7.69 crore. The supplied data confirms a clear same-day share price rise, but it does not establish a company-specific trigger. For readers tracking Kopran Ltd Stock News, the event is relevant because it combines a sharp price move with a valuation profile and healthcare-sector context that can be checked against peers. Univest is following the move through price action, fundamentals and relative positioning rather than guessing at a cause.
The broader question behind Kopran Ltd Share Price Today is not only how far the stock moved, but what the move means in the context of profitability, valuation and sector comparison. Univest analysis below keeps the discussion factual and centred on the supplied numbers, so readers can separate the price rise from the business metrics that remain unchanged by a single trading session.
Kopran Ltd Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 271.5 |
| Previous Close | Rs 249.65 |
| Today's Move | Rs 21.85 (+8.75%) |
| Open | Rs 253.4 |
| High | Rs 274.6 |
| Low | Rs 238.3 |
| Turnover | Rs 7.69 crore |
| Market Capitalisation | Rs 1,137.37 crore |
| Market Cap Category | Small Cap |
Kopran Ltd. (KOPRAN) rose to Rs 271.5 from the previous close of Rs 249.65, a move of Rs 21.85 or 8.75%. The stock opened at Rs 253.4, reached a high of Rs 274.6, recorded a low of Rs 238.3.
Kopran Ltd Share Price today rose 8.75% after opening at Rs 253.40 and reaching an intraday high of Rs 274.60, compared with the previous close of Rs 249.65. The stock ended at Rs 271.50, which is Rs 21.85 above the prior close and close to the upper end of the day’s range. The low for the session was Rs 238.30. That pattern shows a stronger close than the opening level and keeps the move firmly in the category of a same-day price rise. The turnover of Rs 7.69 crore gives a factual measure of traded value for the session. For readers scanning Kopran Ltd Share Price News or Kopran Ltd Stock Gaining Today, the key point is simple: the stock has moved up sharply, and the supplied data records the move without assigning a catalyst. Univest treats this as a verified market event first and a narrative second.
Kopran Ltd. (KOPRAN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,137.37 crore |
| P/E Ratio | 48.25x |
| P/B Ratio | 2.25x |
| ROE | 4.92% |
| ROCE | 6.65% |
| EPS | Rs 5.17 |
| Book Value Per Share | Rs 110.92 |
| Dividend Yield | 1.2% |
Kopran Ltd. (KOPRAN) fundamental metrics show P/E 48.25x, P/B 2.25x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.
Kopran Ltd. has a market capitalisation of Rs 1137.37 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 48.25x, P/B at 2.25x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 5.17, book value per share of Rs 110.92, dividend yield of 1.2%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.74x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 48.25x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 2.25x |
| Benchmark Median P/B | 3.02x |
| Company ROE | 4.92% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 6.65% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 1,137.37 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Kopran Ltd. (KOPRAN) has a P/E ratio of 48.25x, which is above the benchmark median of 31.74x, a difference of +52.02%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.78%, a difference of -58.23%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.65%, a difference of -51.28%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Kopran Ltd. (KOPRAN) has a P/E ratio of 48.25x compared with the displayed peer median of 36.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 1,137.37 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Kopran Ltd
- Kopran Ltd Share Price rose 8.75% today to Rs 271.50 after closing the previous session at Rs 249.65.
- The day’s range was Rs 238.30 to Rs 274.60, and the stock finished near the upper end of that range.
- Market capitalisation is Rs 1,137.37 crore, which places the company above the same-industry median but below the industry average.
- The P/E ratio is 48.25, while ROE is 4.92 and ROCE is 6.65, giving the valuation a clear earnings-and-return context.
- Among the selected healthcare peers, Zydus Lifesciences and Cipla show lower P/E ratios, while Divi’s and Torrent trade at much higher multiples.
About Kopran Ltd
Kopran Ltd operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s listing on NSE and BSE makes Kopran Ltd Share Price relevant for investors following Indian pharmaceutical stocks. The supplied data does not provide a segment split or product mix, so the business description should remain focused on the verified sector and industry identity rather than broader assumptions.
In company-overview terms, Kopran is being tracked here as a listed pharma name with measurable market value, earnings per share, book value and dividend yield. That combination is often what readers use when comparing Kopran Ltd Stock News with other healthcare counters on Univest. The essential takeaway is that Kopran Ltd Share Price today reflects a daily market move, while the company’s long-term operating profile must still be read through the financial and sector data supplied in the same record.
Track Kopran Ltd Share Price on Univest
Use Kopran Ltd. (KOPRAN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Kopran Ltd Share Price live on Univest along with key ratios, market capitalisation, financial analysis, shareholding pattern, 52-week levels and market insights. Univest also helps compare Kopran Ltd Share Price Today with peer companies, sector benchmarks and company fundamentals in one place.
For users following Kopran Ltd Stock News, Univest brings together price rise context, valuation ratios and industry comparison in a clean format. That makes it easier to review Kopran Ltd Share Price Update, Kopran Ltd Fundamental Analysis and Kopran Ltd Stock Analysis without jumping across multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Kopran Ltd Share Price rising today?
Ans. Kopran Ltd Share Price rose 8.75% to Rs 271.50 today, but the supplied data does not establish a company-specific catalyst. The record only confirms the price move, turnover and intraday range.
What is Kopran Ltd Share Price today?
Ans. Kopran Ltd Share Price today is Rs 271.50. That is Rs 21.85 above the previous close of Rs 249.65, and the stock traded between Rs 238.30 and Rs 274.60 during the session.
What is Kopran Ltd market capitalisation?
Ans. Kopran Ltd’s market capitalisation is Rs 1,137.37 crore. In the same-industry benchmark, that is above the median market cap of Rs 750.5 crore and far below the industry average. The company operates in the Healthcare sector.
How does Kopran compare on valuation?
Ans. Kopran trades at a P/E ratio of 48.25 and a P/B ratio of 2.25. Its P/E is above the same-industry median of 31.74, while its P/B sits below the median of 3.02.
What do Kopran’s profitability ratios show?
Ans. Kopran’s ROE is 4.92 and ROCE is 6.65. Both are below the same-industry benchmark median and average, so the ratios provide a weaker return context than several selected peers. ROE stands at 4.92%.
What are Kopran’s EPS, book value and dividend yield?
Ans. Kopran reports EPS of Rs 5.17, book value per share of Rs 110.92 and dividend yield of 1.2. These figures help frame earnings, accounting value and historical payout alongside the price rise.
